ANDERSON DAVID EVANDER (Chief Scientific Officer) received a stock award from VBI VACCINES INC/BC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2019ACC: 0001493152-19-001331
Officer· Chief Scientific Officer
Since Jan 2019
+325K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
325K acquired
Non-Derivative Transactions1
Common Shares, no par value per share
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
24.7%
1/31/2019
101.33K→126.33K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value per share Direct | 1/31/2019 | A · Award | +25K | — | — | 24.7% | 101.33K | 126.33K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Option (Right to Buy Common Shares)
Direct
Converts to
Common Shares
300K shares
Shares
+300K
Strike price
1.67
Held after
300K
Exercisable
—
1/31/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (Right to Buy Common Shares) Direct | Common Shares300K shares | 1/31/2019 | A · Award | +300K | 1.67 | — | 300K |